临床试验/CTRI/2014/03/004462

CTRI/2014/03/004462已完成4 期

An open, prospective, single centre study to assess the confidence, usability, preference and satisfaction on use of Zerostat V Spacer in healthy volunteers and in subjects with mild asthma or COPD.

Cipla Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

阶段: 4 期
状态: 已完成
发起方: Cipla Ltd
入组人数: 30

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

入选标准

•1. Subjects and healthy volunteers willing to sign informed consent
•2. Subjects and healthy volunteers of 18 years and above
•3. Subjects with or without a respiratory condition. Each subject with a
•respiratory condition (prior experience of using an device) should be
•matched as far as possible with an individual without a respiratory
•condition (device naÃ¯ve) with respect to the age, sex, literacy status
•4. Subjects with mild Asthma or COPD or healthy volunteer

排除标准

•1. Subjects already using Zerostat-V spacer prior to start of the study.
•2. Subjects with co-ordination problems like Parkinsonâ??s disease, mental
•illness, tremors etc.

研究者

发起方

相似试验

Study to assess the confidence, usability,preference and satisfaction on use of Zerostat spacer in healthy volunteersand in subjects with mild Asthma or COPD.

CTRI/2014/03/004448Cipla Ltd30

A clinical trial to assess the confidence, usability, preference and satisfaction on use of Baby Mask with valve from parents of children who are healthy or who have mild Asthma.

CTRI/2009/091/000958Cipla Ltd30

Study to assess the confidence, usability, preference and satisfaction on use of Zerostat-VT Spacer in healthy volunteers and in subjects with mild asthama or COPD

CTRI/2014/02/004432Cipla Ltd30

A clinical trial to assess the confidence, usability, preference and satisfaction on use of peak flow master in healthy volunteers and in subjects with mild Asthma or COPD.

CTRI/2009/091/000586Cipla Ltd30

进行中（未招募）

Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinomaStudy PICABAS

EUCTR2017-004608-22-FRCHU de Nice28